Skip to content

AARD AARD Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Viking Therapeutics logo
Viking TherapeuticsVKTX
$1.29M-58.7%
Arvinas logo
ArvinasARVN
$1.7M-55.3%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$1.03M-55.2%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$3M-25.0%

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's accretion (amortization) of discounts and premiums, investments?
AARD (AARD) reported accretion (amortization) of discounts and premiums, investments of $118K in Q1 2026.
How has AARD's accretion (amortization) of discounts and premiums, investments changed year-over-year?
AARD's accretion (amortization) of discounts and premiums, investments increased by 45.7% year-over-year, from $81K to $118K.
What does accretion (amortization) of discounts and premiums, investments mean?
Reflects the non-cash adjustment to the carrying value of investment securities resulting from the amortization of premiums or the accretion of discounts. This ensures that the interest income recognized on the income statement aligns with the effective yield of the investment portfolio.